品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | P127261-5mg | 5mg | 现货 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-10mg | 10mg | 现货 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-50mg | 50mg | 现货 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-100mg | 100mg | 现货 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-25mg | 25mg | 现货 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P420608-1ml | 1ml | 现货 | 1109276-89-2 |
PF-04620110 PF-04620110 |
Moligand™, 10mM in DMSO |
|
|
麦克林 | P872562-5mg | 5mg | 订前询问 | 1109276-89-2 |
PF-04620110 PF-04620110 |
0.99 |
|
|
罗恩 | R032632-5mg | 5mg | 现货 | 1109276-89-2 |
反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并... PF-04620110 |
99% |
|
|
MARY | MR143743-5mg | 5mg | 订前咨询 | 1109276-89-2 |
反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并... PF-04620110 |
99% |
|
|
源叶 | S81211-5mg | 5mg | 期货,请咨询 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-10mg | 10mg | 期货,请咨询 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-50mg | 50mg | 期货,请咨询 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-25mg | 25mg | 期货,请咨询 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-100mg | 100mg | 期货,请咨询 | 1109276-89-2 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S56489-1ml | 1ml | 期货,请咨询 | 1109276-89-2 |
PF-04620110 PF-04620110 |
10mM in DMSO |
|
|
毕得 | BD245855-10mg | 10mg | 现货 | 1109276-89-2 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|
毕得 | BD245855-50mg | 50mg | 现货 | 1109276-89-2 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|
毕得 | BD245855-100mg | 100mg | 现货 | 1109276-89-2 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|
毕得 | BD245855-25mg | 25mg | 现货 | 1109276-89-2 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|